Event Name: BIO CEO & Investor Conference; New Treatments for Diabetes and Obesity: Innovations for Chronic Diseases Panel
Date: February 12, 2019
Panel Description: BIO research on venture funding trends shows a long-term slowdown in overall investment in chronic diseases, despite their large patient populations, but with recent signs of hope in investor support for new treatments for diabetes and obesity. This session will detail those drug pipelines, which research approaches are convincing skeptical investors, as well as the sources of investor resistance, plus opportunities for streamlining high-cost clinical trials in these disease areas through application of digital technologies.
Organized by: Biotechnology Innovation Organization
Location: New York City, NY
T1D Exchange Attendees: Dara Schuster, MD